11/8/2024  9:58:32 PM Chg. +1.57 Volume Bid10:00:09 PM Ask10:00:09 PM Market Capitalization Dividend Y. P/E Ratio
219.11USD +0.72% 42,136
Turnover: 4.77 mill.
-Bid Size: - -Ask Size: - 39.79 bill.USD - 29.67

Business description

IQVIA is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward.
 

Management board & Supervisory board

CEO
Ari Bousbib
Management board
Ron Bruehlman, Trudy Stein, Karl Guenault, Kevin Knightly, Sanjay Chikarmane, Jim Berkshire, Eric Sherbet
Supervisory board
Ari Bousbib, Carol J. Burt, John P. Connaughton, John G. Danhakl, James A. Fasano, Colleen Goggins, John M. Leonard, Leslie Wims Morris, Todd B. Sisitsky, Sheila A. Stamps
 

Company data

Name: IQVIA Holdings Inc.
Address: 2400 Ellis Road,Durham, North Carolina 27703,USA
Phone: +1-203-448-4663
Fax: -
E-mail: -
Internet: https://www.iqvia.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: -
IPO date: -

Investor relations

Name: Nick Childs
IR phone: +1-973-316-3828
IR Fax: -
IR e-mail: ir@iqvia.com

Main Shareholders

Others
 
58.37%
Vanguard Group
 
11.56%
BlackRock Inc.
 
8.32%
HARRIS ASSOCIATES L P
 
5.35%
State Street Corporation
 
4.34%
ALLIANCEBERNSTEIN L P
 
2.60%
Morgan Stanley
 
2.22%
GEODE CAPITAL MANAGEMENT LLC
 
2.21%
LAZARD ASSET MANAGEMENT LLC
 
1.77%
Others
 
3.26%